Christian Faul Selected Research

Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)

1/2022	Soluble α-klotho and heparin modulate the pathologic cardiac actions of fibroblast growth factor 23 in chronic kidney disease.
1/2021	Fibroblast growth factor 23 (FGF23) induces ventricular arrhythmias and prolongs QTc interval in mice in an FGF receptor 4-dependent manner.
1/2020	Fibroblast Growth Factor Receptor 4 Deficiency Mediates Airway Inflammation in the Adult Healthy Lung?
10/2019	FGFR4 does not contribute to progression of chronic kidney disease.
1/2018	Fibroblast growth factor 23 and Klotho contribute to airway inflammation.
9/2017	Vitamin D treatment attenuates cardiac FGF23/FGFR4 signaling and hypertrophy in uremic rats.
1/2017	FGF23/FGFR4-mediated left ventricular hypertrophy is reversible.
1/2016	The role of fibroblast growth factor 23 and Klotho in uremic cardiomyopathy.
11/2014	Treatment of established left ventricular hypertrophy with fibroblast growth factor receptor blockade in an animal model of CKD.
5/2014	Paricalcitol downregulates myocardial renin-angiotensin and fibroblast growth factor expression and attenuates cardiac hypertrophy in uremic rats.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Christian Faul Research Topics

Disease

15	Chronic Renal Insufficiency 01/2022 - 07/2012
11	Proteinuria 01/2019 - 07/2005
10	Inflammation (Inflammations) 01/2022 - 11/2016
8	Cardiomegaly (Heart Hypertrophy) 01/2022 - 05/2014
8	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 10/2019 - 07/2012
7	Kidney Diseases (Kidney Disease) 01/2022 - 05/2004
7	Nephrotic Syndrome (Syndrome, Nephrotic) 01/2019 - 05/2004
6	Fibrosis (Cirrhosis) 08/2022 - 11/2014
6	Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal) 01/2019 - 07/2005
4	Hypertrophy 01/2022 - 11/2011
4	Neoplasms (Cancer) 01/2018 - 05/2005
3	Renal Insufficiency (Renal Failure) 01/2022 - 07/2005
3	Chronic Obstructive Pulmonary Disease (COPD) 01/2020 - 01/2018
2	Insulin Resistance 01/2022 - 03/2011
2	Hyperphosphatemia 01/2022 - 07/2017
2	Heart Failure 01/2022 - 07/2017
2	Anemia 01/2022 - 08/2019
2	Apnea 01/2020 - 08/2018
2	Chronic Kidney Failure (Chronic Renal Failure) 01/2019 - 01/2017
2	Cystic Fibrosis (Mucoviscidosis) 01/2019 - 10/2017
2	Cardiomyopathies (Cardiomyopathy) 07/2017 - 01/2016
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2017 - 07/2012
2	Pulmonary Hypertension 06/2012 - 03/2012
2	Pulmonary Arterial Hypertension 06/2012 - 03/2012
1	Type 2 Diabetes Mellitus (MODY) 01/2022
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2022
1	Obstructive Sleep Apnea 01/2020
1	Wounds and Injuries (Trauma) 10/2019
1	Hypertension (High Blood Pressure) 01/2019
1	Lung Diseases (Lung Disease) 01/2019
1	Hereditary Nephritis (Alport Syndrome) 01/2019
1	Lipoid Nephrosis (Glomerulonephritis, Minimal Change) 01/2019
1	Disease Progression 01/2019
1	Idiopathic Pulmonary Fibrosis 01/2019
1	Pneumocystis Pneumonia (Pneumocystis carinii Pneumonia) 01/2018
1	Pneumothorax 01/2018
1	Acute-Phase Reaction 10/2017
1	Endotoxemia 10/2017
1	Vitamin D Deficiency 09/2017
1	Chronic Kidney Disease-Mineral and Bone Disorder (Renal Rickets) 01/2017
1	Albuminuria 01/2016
1	Diabetic Nephropathies (Diabetic Nephropathy) 01/2016
1	Food Intolerance 01/2016

Drug/Important Bio-Agent (IBA)

16	Fibroblast Growth Factor-23IBA 01/2022 - 07/2012
11	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 01/2022 - 11/2011
10	Hormones (Hormone)IBA 01/2022 - 07/2012
9	Proteins (Proteins, Gene)FDA Link 01/2022 - 05/2005
8	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 01/2022 - 05/2014
7	Phosphates (Orthophosphate)IBA 01/2022 - 06/2015
6	CalcineurinIBA 01/2019 - 09/2008
4	CytokinesIBA 10/2019 - 03/2011
3	Pharmaceutical PreparationsIBA 08/2022 - 05/2004
3	SteroidsIBA 01/2019 - 08/2013
3	Biomarkers (Surrogate Marker)IBA 01/2017 - 12/2013
3	TRPC6 Cation ChannelIBA 12/2013 - 07/2005
2	Heparin (Liquaemin)FDA LinkGeneric 01/2022 - 03/2004
2	Protein Isoforms (Isoforms)IBA 01/2022 - 07/2017
2	Type 4 Fibroblast Growth Factor ReceptorIBA 01/2020 - 12/2015
2	MineralsIBA 08/2019 - 01/2017
2	CreatinineIBA 01/2019 - 05/2014
2	paricalcitol (Zemplar)FDA Link 01/2019 - 05/2014
2	Vitamin D FDA LinkGeneric 09/2017 - 05/2014
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 12/2012 - 10/2011
2	Protamines (Protamine Sulfate)FDA Link 08/2007 - 05/2005
1	Peptides (Polypeptides)IBA 08/2022
1	Adenine FDA LinkGeneric 01/2022
1	A-factor (Streptomyces)IBA 01/2022
1	HepcidinsIBA 01/2022
1	fibroblast growth factor 21IBA 01/2022
1	Monoclonal AntibodiesIBA 01/2021
1	Oxygen (Dioxygen)IBA 01/2020
1	IronIBA 08/2019
1	Antisense OligonucleotidesIBA 01/2019
1	zonulinIBA 01/2019
1	Discoidin Domain Receptor 1IBA 01/2019
1	Bleomycin (Blenoxane)FDA LinkGeneric 01/2019
1	DNA (Deoxyribonucleic Acid)IBA 01/2019
1	Calcitriol Receptors (Calcitriol Receptor)IBA 01/2019
1	Troponin IIBA 08/2018
1	fibrin fragment D (D-dimer)IBA 08/2018
1	SmokeIBA 01/2018
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 01/2018
1	InterleukinsIBA 10/2017
1	Interleukin-8 (Interleukin 8)IBA 10/2017
1	Transforming Growth Factors (Transforming Growth Factor)IBA 10/2017
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 10/2017
1	Calcitriol (Calcijex)FDA LinkGeneric 09/2017
1	C-Reactive ProteinIBA 01/2017
1	Interleukin-6 (Interleukin 6)IBA 01/2017
1	CyclodextrinsIBA 01/2016
1	Type I Tumor Necrosis Factor ReceptorsIBA 01/2016
1	CholesterolIBA 01/2016
1	Type II Tumor Necrosis Factor ReceptorsIBA 01/2016
1	Glutens (Glutelin)IBA 01/2016

Therapy/Procedure

4	Therapeutics 01/2022 - 02/2014
2	Renal Dialysis (Hemodialysis) 01/2022 - 01/2019
1	Chest Tubes (Chest Tube) 01/2018
1	Pleurodesis 01/2018
1	Catheters 01/2018
1	Gluten-Free Diet 01/2016